MedImmune Ventures is a venture capital firm that is invested in healthcare technology companies. The firm was founded in 2002 in Gaithersburg, Maryland, United States, and is a sub-organization of MedImmune.
The fund is a wholly owned venture fund within the AstraZeneca/MedImmune group of companies. The firm looks to discover, develop, commercialize, and finance new biotechnology products in order to transform them from products to companies. Public and private companies are attractive to the firm.
A company developing small molecule therapies to treat cancer
A pharmaceutical company engaged in the discovery and development of medicines for inflammatory conditions
A company developing small molecule inhibitors of arginase and serotonin therapeutics for pulmonary and critical cases
A biopharmaceutical company developing drugs to treat pain, inflammation, anxiety and other diseases
A company developing vaccines for flu, malaria, dengue, papillomavirus and respiratory syncytial virus
A company that develops vaccines and monoclonal antibodies to treat gastrointestinal and respiratory conditions
A biotechnology company developing treat ments for sickle cell disease, cancer, asthma autoimmune and inflammatory diseases
A biotechnology developing drug to stimulate the growth of new neurons
Applied Genetic Technologies Corporation is an Alachua, Florida-based biotechnology company founded in 2001.
Melinta Therapeutics is a New Haven, Connecticut-based company.
A biopharmaceutical company that develops drugs for autoimmune and inflammatory diseases
A company developing antiviral medicines focused on ffighting drug-resistant viruses